JPMORGAN CHASE & CO - 31 Dec 2025 SCHEDULE 13G/A Report for RADIOPHARM THERANOSTICS LIMITED Ordinary Shares, as represented by American Depositary Shares (RADX)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: RADIOPHARM THERANOSTICS LIMITED Ordinary Shares, as represented by American Depositary Shares
Symbol: RADX
Shares outstanding: 3,641,998,775 shares
Disclosed Ownership: 145,679,951 shares
Ownership: 4%
Form type: SCHEDULE 13G/A
Filing time: 16 Jan 2026, 11:31:34 UTC
Date of event: 31 Dec 2025
Previous filing: 16 Jul 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	4%	145,679,951	145,679,951	0	Rachel Tsvaygoft	Vice President